UK Records 2,657 Coronavirus Cases    Brazil Records 74,592 New Virus Infections and 2,383 Deaths    Algeria Records 207 Coronavirus Cases    Jordan Condemns Terrorist Houthi Militia's Launching of Drones, Ballistic Missiles towards Saudi Arabia    Inflation matters, but Fed policy matters more.    Big Oil could see proven reserves run out in less than 15 years as output is not replaced by discoveries    Custodian of the Two Holy Mosques Receives Phone Call from Iraqi Prime Minister    SITA marks a 25-year milestone in border management    Jordan Motorsport unveils route details for 2021 Jordan Rally    Nominations for 5th edition of Sunhak Peace Prize opens    Remarkable collection of Syrian art transcends horrors of war: Arte Arta Gallery    MoHAP approves emergency use of Pfizer-BioNTech vaccine for 12-15 age group    Ministry of Health Urge the Public to Apply Social Distancing, During Eid Holiday    Champions League final 2021 moved from Istanbul to Porto's Estádio do Dragão    New COVID-19 cases stay above 1,000 in Saudi Arabia as recoveries continue to surge    Saudi, French officials release first details of Dakar 2022    'Be careful', health minister warns of laxity in precautionary measures ahead of Eid    Italy fines Google €102 million for abuse of dominant position    Coalition intercepts and destroys three Houthi ballistic missiles, eight drones    HRH Crown Prince Congratulates Personnel of Ministry of Defense on Advent of Eid Al-Fitr    Custodian of the Two Holy Mosques Performs Eid Al-Fitr Prayer    US president speaks to Israeli PM, hopes violence ending 'sooner than later'    KSrelief carries out zakat distribution project in number of countries    Prospects of preparing playgrounds in partnership with private sector explored    Saudi Arabia discovers new archaeological site dating back to 350,000 years    Organ donation a good deed, says Council of Senior Scholars    Tawakkalna Launches Registration Service to Donate Organs on its Website    King Salman, Crown Prince sign up for organ donation program    'Love & Inspire' art exhibition supports 'Smile' Initiative    GASTAT Publishes Flash Estimates of Real GDP Growth Rate for Q1 of 2021    Al-Falih: Saudi-Pakistani Supreme Coordination Council Opens Wider Horizons for Economic Growth    United World, ITC Sign Three-year Partnership to Launch Sports for Development    Citizen Account Wins UN WSIS Prize for E-Government Track    From whom do we take Shariah? How do we get legitimacy?    Sheikh Salman Al Khalifa: Saudi Football Association is distinguished and professional    Saudi Rower Hussain Alireza sets for 2021 Tokyo Olympics qualifiers    Asian Handball Championships' Draw to Take Place in Jeddah on Saturday    President of Union of Arab Football Associations Meets with Heads of FIFA, AFC and CAF    Business Lady Led Saudi World Competitiveness Edge, in Banana Planting    Al-Khawada Constitutes One of Khulays Governorate Traditional Dishes    Indian Community in Rafha Recalls Ramadan Habits    Welcome to beautiful Ramadan customs    Vaccination does not invalidate fasting, says UAE Fatwa Council    It is high time to correct wrong concepts about women's status    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    Senior Scholars Council Issues Decision No. 246 Regarding Attendance of Friday Prayer and Prayers at Mosques in a Case of Spread of Epidemic or Fear of its Spread    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Alert over shortage of new drugs for 'world's most dangerous bacteria'
Published in The Saudi Gazette on 16 - 04 - 2021

A lack of new treatments for common infections has left people dangerously exposed to the "world's most dangerous bacteria", the UN health agency said on Thursday.
The alert from the World Health Organization (WHO) is delivered in a report showing that none of the 43 antibiotics in development today sufficiently addresses the growing threat posed by 13 priority drug-resistant bacteria.
"The persistent failure to develop, manufacture, and distribute effective new antibiotics is further fuelling the impact of antimicrobial resistance and threatens our ability to successfully treat bacterial infections," said Dr. Hanan Balkhy, WHO Assistant director-general on antimicrobial resistance.
Those most at risk are young children and those living in poverty, but antibiotic-resistant infections can affect anyone, said WHO partner AMR.
Youngsters at risk
According to WHO, three in 10 newborns who develop blood infections die, because the antibiotics that are used to treat sepsis are no longer effective.
Bacterial pneumonia — another preventable illness that has developed resistance to available drugs – is also a major cause of childhood mortality among under-fives.
WHO's annual Antibacterial Pipeline Report, notes that almost all antibiotics available today are variations of those discovered by the 1980s.
We rely hugely on them in all areas of our lives, from having a tooth out at the dentist, to organ transplants and cancer chemotherapy.
Unproductive pipeline
But after reviewing antibiotics that are in the clinical stages of testing, as well as those in development, the report highlighted a "near static pipeline" of production, which WHO's Haileyesus Getahun likened to the "Achilles heel" of global health security.
"Opportunities emerging from the COVID-19 pandemic must be seized to bring to the forefront the need for sustainable investments in research and development of new and effective antibiotics," said Mr. Getahun, WHO Director of Antimicrobial Resistance Global Coordination.
"We need a global sustained effort including mechanisms for pooled funding and new and additional investments to meet the magnitude of the antimicrobial threat."
Only a few drugs have been given early-stage approval by regulators in recent years "and most of these agents...offer limited clinical benefit over existing treatments, WHO said, with the warning that the "rapid emergence of drug-resistance to these new agents" was a certainty.
Fractional gains
This was despite the fact that "some promising products" were in different stages of development, as only a fraction of these will make it to market in a sector hampered by the small return on investment from successful antibiotic products, which has limited the interest of most large pharmaceutical companies.
"Overall, the clinical pipeline and recently approved antibiotics are insufficient to tackle the challenge of increasing emergence and spread of antimicrobial resistance," the UN agency concluded.
Driving research
To promote investment in antibiotics development, WHO and partner Drugs for Neglected Diseases initiative (DNDi) have set up the Global Antibiotic R&D Partnership (GARDP) to develop innovative treatments.
The UN health agency has also been working closely with other non-profit funding partners such as the CARB-X to accelerate antibacterial research.
Another important new WHO-partnered initiative is the AMR Action Fund, that was set up by pharmaceutical companies, philanthropists and the European Investment Bank; its aim is to strengthen and accelerate antibiotic development through pooled funding. — UN news


Clic here to read the story from its source.